GlassScriptPhysician profile
Fredrick Wittleder
NPI 1205195088
$4,076.50
in general payments reported to CMS, 2019-2025
16 companies · $1,339 in 2025
The $1,339 reported for 2025 was more than what 93% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $509 · 2022: $475 · 2023: $373 · 2024: $1,380 · 2025: $1,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,750 · Food and Beverage: $1,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,750.09 |
| Food and Beverage | $1,343.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $1,320.18 | 2025 | Ha Minuteman G3-R, Liberty Si, Patriot Si |
| Boston Scientific Corporation | $1,286.36 | 2021-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $625.99 | 2021-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Accurian |
| Relievant Medsystems, INC. | $224.62 | 2021-2023 | Intracept |
| Grt US Holding, INC. | $180.77 | 2022 | |
| Averitas Pharma INC. | $90.46 | 2024 | Qutenza |
| Pfizer INC. | $81.55 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $79.55 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.65 | 2024 | Relistor |
| Teva Pharmaceuticals USA, INC. | $22.72 | 2022 | |
| Nalu Medical, INC. | $22.17 | 2022 | |
| Nevro Corp. | $18.75 | 2024 | Senza |
| Amgen INC. | $16.31 | 2022 | |
| Redhill Biopharma INC. | $13.18 | 2021 | |
| Abbvie INC. | $13.06 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $11.18 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fredrick Wittleder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.